PATENT CLAIM ANALYSIS

Application Number: 15963535
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "210200"]

Abstract:
The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.

Claim (Index 5):
The compound according to  claim 1 , wherein\n R 3  is selected from or R 3  and R 4  together with the nitrogen atom to which they are attached form a ring selected from or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15303879', '15303868', '15303890', '12765904', '15736450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.823109041586394
- 35 USC 102 Novelty (BERT): 0.6160937502095997
- Combined Prediction Score: 0.8024075124487146
- Mean Citation Score: 436.623092
- Max Citation Score: 539.0702
- Similarity Product: 535.8929495159626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test